These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 37604793

  • 21. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.
    Wang X, Van Lookeren Campagne M, Katschke KJ, Gullipalli D, Miwa T, Ueda Y, Wang Y, Palmer M, Xing G, Song WC.
    J Am Soc Nephrol; 2018 Aug; 29(8):2053-2059. PubMed ID: 29895552
    [Abstract] [Full Text] [Related]

  • 22. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
    Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G, EAGLE Study Group.
    Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
    [Abstract] [Full Text] [Related]

  • 23. [Membranoproliferative glomerulonephritis and C3 glomerulopathy].
    Hohenstein B, Amann K, Menne J.
    Internist (Berl); 2019 May; 60(5):458-467. PubMed ID: 30859280
    [Abstract] [Full Text] [Related]

  • 24. FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy.
    Garam N, Cserhalmi M, Prohászka Z, Szilágyi Á, Veszeli N, Szabó E, Uzonyi B, Iliás A, Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G, Bajcsi D, Brunner J, Dumfarth A, Cejka D, Flaschberger S, Flögelova H, Haris Á, Hartmann Á, Heilos A, Mueller T, Rusai K, Arbeiter K, Hofer J, Jakab D, Sinkó M, Szigeti E, Bereczki C, Janko V, Kelen K, Reusz GS, Szabó AJ, Klenk N, Kóbor K, Kojc N, Knechtelsdorfer M, Laganovic M, Lungu AC, Meglic A, Rus R, Kersnik Levart T, Macioniene E, Miglinas M, Pawłowska A, Stompór T, Podracka L, Rudnicki M, Mayer G, Rysava R, Reiterova J, Saraga M, Seeman T, Zieg J, Sládková E, Stajic N, Szabó T, Capitanescu A, Stancu S, Tisljar M, Galesic K, Tislér A, Vainumäe I, Windpessl M, Zaoral T, Zlatanova G, Józsi M, Csuka D.
    Front Immunol; 2021 May; 12():720183. PubMed ID: 34566977
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Unsupervised Clustering of Membranoproliferative Glomerulonephritis and C3 Glomerulopathy Patients Discovers Distinct Patient Groups unlike the Current Classification.
    Kovala M, Seppälä M, Wojnicki M, Honkanen E, Meri S, Kaartinen K, Räisänen-Sokolowski A.
    Nephron; 2024 May; 148(11-12):734-743. PubMed ID: 38964287
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. C3 Glomerulopathy.
    Riedl M, Thorner P, Licht C.
    Pediatr Nephrol; 2017 Jan; 32(1):43-57. PubMed ID: 27056062
    [Abstract] [Full Text] [Related]

  • 32. Update on C3 Glomerulopathy: A Complement-Mediated Disease.
    Caravaca-Fontán F, Lucientes L, Cavero T, Praga M.
    Nephron; 2020 Jan; 144(6):272-280. PubMed ID: 32369815
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y, Ishikura K, Hamada R, Harada R, Sakai T, Hamasaki Y, Hataya H, Fukuzawa R, Ogata K, Honda M.
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [Abstract] [Full Text] [Related]

  • 36. Toward a working definition of C3 glomerulopathy by immunofluorescence.
    Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD.
    Kidney Int; 2014 Feb; 85(2):450-6. PubMed ID: 24067430
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN.
    Meuleman MS, Vieira-Martins P, El Sissy C, Audard V, Baudouin V, Bertrand D, Bridoux F, Louillet F, Dossier C, Esnault V, Jourde-Chiche N, Karras A, Morin MP, Provot F, Remy P, Ribes D, Rousset-Rouviere C, Servais A, Thervet E, Tricot L, Zaidan M, Wynckel A, Zuber J, Le Quintrec M, Frémeaux-Bacchi V, Chauvet S.
    Clin J Am Soc Nephrol; 2023 Nov 01; 18(11):1435-1445. PubMed ID: 37615951
    [Abstract] [Full Text] [Related]

  • 39. To interpret and analyze the changing patterns of histology and direct immunofluorescence findings in membranoproliferative glomerulonephritis.
    Nayak PP, Pradhan P, Pradhan D, Mohapatra N, Raman S, Sahoo P.
    Indian J Pathol Microbiol; 2024 Nov 01; 67(1):80-85. PubMed ID: 38358193
    [Abstract] [Full Text] [Related]

  • 40. Morphological and etiological analyses of C3 and non-C3 glomerulonephritis in primary membranoproliferative glomerulonephritis using periodic acid-methenamine silver stain electron microscopy: a retrospective multicentered study.
    Honma S, Sato N, Sakaguchi R, Hashiguchi A, Uesugi N, Nakamura Y, Sasano H, Joh K.
    Med Mol Morphol; 2024 Mar 01; 57(1):23-34. PubMed ID: 37823929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.